MetaVia has formally selected Sarah Browne to serve as its new chief medical officer. The career shift was featured as part of an industry roundup tracking major executive movements. Before stepping into this position, Browne advised Soufflé Therapeutics as a clinical development consultant and previously served as vice president of clinical development at Altimmune.
Key points
MetaVia has secured an executive with senior-level clinical development experience to gui…: MetaVia has secured an executive with senior-level clinical development experience to guide its medical leadership.
Sarah Browne's career transition highlights ongoing executive mobility and recruitment ac…: Sarah Browne's career transition highlights ongoing executive mobility and recruitment across the biopharmaceutical landscape.
The appointment reflects Browne's progression from strategic consultancy and vice preside…: The appointment reflects Browne's progression from strategic consultancy and vice presidential roles to chief medical officer.
Sources checked by our analysis pipeline: 1
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that MetaVia hired Sarah Browne as chief medical officer. Previously, she was a clinical development consultant to Soufflé Therapeutics and, prior to that, she was vice president, clinical development at Altimmune.
But all work and no play can make for a dull chief medical officer.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
The Y Combinator-backed company is expanding its commercial team to accelerate market adoption of automated regulatory tools. New personnel will focus on driving outreach and identifying prospective clients requiring modern compliance solutions. This staffing push supports broader efforts to scale business operations and increase software adoption.
The Department of Defense is targeting foreign supply chain dependencies by backing a manufacturing facility in Tennessee designed to bypass Chinese components. Founded twelve years ago in Massachusetts, 6K will establish advanced production capabilities to support both military hardware and commercial applications. The project provides critical federal momentum after previous clean energy financing efforts suffered major regulatory setbacks.
The Spanish infrastructure group is considering a deal to absorb the remaining shares of its construction arm in Germany. Pursuing this full integration would consolidate the parent company's operational footprint across key European and international markets. The strategic maneuver is currently under evaluation as reported by Bloomberg News.